GLP-1 (7-36) Amide

Native GLP-1 peptide fragment. Short-acting precursor to semaglutide and liraglutide analogs.

✅ Potential Benefits

Stimulates insulin secretion glucose-dependently
Reduces glucagon release
Slows gastric emptying
Reduces appetite and food intake
Cardiovascular protective effects
Neuroprotective in research models

💊 Dosing Protocol

Very short half-life makes SubQ impractical. Research use mainly IV.

⏱ Half-Life

~1–2 minutes (rapidly degraded by DPP-4)

⚠️ Common Side Effects

Nausea, hypoglycemia in high doses.

🚫 Warnings & Contraindications

Native form impractical for therapeutic use due to very short half-life
Long-acting analogs (semaglutide, liraglutide) are preferred clinically

🚨 Adverse Effects

Hypoglycemia if not glucose-dependent dosing. GI upset.

📬 Interested in GLP-1?

Have questions about this peptide or want to discuss availability?

✉️ Send an Inquiry

⚕️ This information is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before beginning any wellness protocol.

Track your GLP-1 protocol in the app

Calculate exact doses, schedule injections, journal your progress.

🚀 Try Free for 7 Days